TAPE WORM TABS DOGS- praziquantel tablet 
ProLabs, Ltd.

----------

TAPE WORM TABS® (praziquantel)
Tapeworm tablets for dogs and puppies

 

Each Tablet Contains 34 mg Praziquantel.

DESCRIPTION:

Tape Worm Tabs® (praziquantel) tapeworm tablets for dogs and puppies are sized for easy oral administration to either adult dogs or puppies. The tablets may be given directly in the mouth or crumbled and mixed with the food. If given with food, mix the tablet(s) with a small amount of the animal’s usual ration. If all of the tablet(s) is/are not eaten, Tape Worm Tabs® tapeworm tablets may not remove all tapeworms.

USES:

Tape Worm Tabs® (praziquantel) tapeworm tablets will remove the common tapeworms, Dipylidium caninum and Taenia taeniaeformis, from dogs and puppies.

DIRECTIONS FOR USE:

Tapeworm infection is one of the most common internal parasite problems actually observed by dog owners. The presence of tapeworms is indicated by the presence of tapeworm segments passed with the feces. Tapeworm segments are white, pinkish-white or yellow-white and similar in size and shape to flattened grains of rice. The segments are most frequent observed lying on the animal’s droppings or, less often, moving across a freshly passed stool. Segments are also found on the hair around the anus of the animal, or occasionally on the animal’s bedding. Dogs become infected with tapeworms after eating fleas or small rodents (rats, mice) which are infected with tapeworm larvae. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

DOSAGE AND ADMINISTRATION:

Administer to dogs and puppies* only as follows:

5 pounds and under…………………1/2 tablet
6-10 pounds………………………….1 tablet
11-15 pounds………………………..1 ½ tablets
16-30 pounds………………………..2 tablets
31-45 pounds………………………..3 tablets
46-60 pounds………………………..4 tablets
Over 60 pounds……………………..5 tablets maximum

*Not intended for use in puppies less than 4 weeks of age.

FASTING IS NEITHER NECESSARY NOR RECOMMENDED

RETREATMENT:

Steps should be taken to control fleas and rodents on the premises in order to prevent reinfection; otherwise, retreatment will be necessary. This is especially true in cases of tapeworms transmitted by fleas (Dipylidium caninum) where reinfection is almost certain to occur if fleas are not removed from the animal and its environment. If reinfection occurs, tapeworm segments may be observed within one month of the initial treatment.

SIDE EFFECTS:

Isolated incidents of either vomiting, diarrhea, poor appetite or listlessness have been reported following treatment, but were considered non-significant. If these signs are observed and they persist, consult your veterinarian.

WARNING:

Consult your veterinarian before administering tablets to weak or debilitated animals.

WARNING: Keep out of the reach of children. Not for human use.

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – carton label

Tape Worm Tabs (praziquantel) for Dogs carton label

ProLabs

Tape Worm Tabs®
(praziquantel)

Tapeworm tablets for dogs and puppies

For removal of tapeworm (Dipylidium caninum and Taenia taeniaeformis) from dogs and puppies.

WARNING: KEEP OUT OF REACH OF CHILDREN
NOT FOR HUMAN USE

Contents: 5 Tablets
Read entire card before using this product

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – bottle label

Tape Worm Tabs (praziquantel) for Dogs bottle label

ProLabs

Tape Worm Tabs®
(praziquantel)

Tapeworm tablets for dogs and puppies

Contents: 5 Tablets
Each tablet contains 34 mg praziquantel

TAPE WORM TABS DOGS 
praziquantel tablet
Product Information
Product Type OTC ANIMAL DRUG Item Code (Source) NDC:58909-513
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PRAZIQUANTEL (UNII: 6490C9U457) (PRAZIQUANTEL - UNII:6490C9U457) PRAZIQUANTEL 34 mg
Product Characteristics
Color WHITE Score 2 pieces
Shape OVAL Size 13mm
Flavor Imprint Code PL2
Contains     
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:58909-513-01 1 in 1 CARTON
1 5 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA111798 03/01/2002
Labeler - ProLabs, Ltd. (962129602)
Registrant - Bayer HealthCare, LLC (152266193)
Establishment
Name Address ID/FEI Business Operations
Merck KGaA 342249299 API MANUFACTURE

Revised: 2/2013
Document Id: 739e791c-fd87-46f9-bf01-a16e6136bc53
Set id: 739e791c-fd87-46f9-bf01-a16e6136bc53
Version: 1
Effective Time: 20130201
 
ProLabs, Ltd.